Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Circadian Technologies Ltd

+ Add to Watchlist

CIR:AU

0.1700 AUD 0.0050 3.03%

As of 19:02:18 ET on 03/26/2015.

Snapshot for Circadian Technologies Ltd (CIR)

Open: 0.1700 Day's Range: 0.1700 - 0.1700 Volume: 12,500
Previous Close: 0.1650 52wk Range: 0.1500 - 0.2800 1-Yr Rtn: -15.00%

Stock Chart for CIR

No chart data available.
  • CIR:AU 0.1700
  • 1D
  • 1M
  • 1Y
0.1650
Interactive CIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CIR

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0958
Est. EPS (AUD) (06/2015) -
Est. PEG Ratio -
Market Cap (M AUD) 24.43
Shares Outstanding (M) 148.09
30 Day Average Volume 42,029
Price/Book (mrq) 0.8671
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (AUD) 0.1466
Dividend Ex-Date 02/04/2005
5 Year Dividend Growth -
Next Earnings Announcement 08/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CIR

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for CIR

Circadian Technologies Limited is active in the management and funding of pharmaceutical research and development projects with Australian and New Zealand Universities allowing the Company to seek licensing arrangements with major international pharmaceutical companies. Circadian's projects include cancer research, metabolic diseases and brain behavior research.

Megan BaldwinManaging Director/CEOMichael Tonroe "Mike"CFO/Secretary
More Company Profile & Key Executives for CIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil